Prevention of stroke: a global perspective
Along with the rising global burden of disability attributed to stroke, costs of stroke care are
rising, providing the impetus to direct our research focus towards effective measures of …
rising, providing the impetus to direct our research focus towards effective measures of …
Medication adherence in cardiovascular medicine
ST Simon, V Kini, AE Levy, PM Ho - Bmj, 2021 - bmj.com
Cardiovascular disease is the leading cause of death globally. While pharmacological
advancements have improved the morbidity and mortality associated with cardiovascular …
advancements have improved the morbidity and mortality associated with cardiovascular …
[HTML][HTML] Polypill strategy in secondary cardiovascular prevention
JM Castellano, SJ Pocock, DL Bhatt… - … England Journal of …, 2022 - Mass Medical Soc
Background A polypill that includes key medications associated with improved outcomes
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
Background A fixed-dose combination therapy (polypill strategy) has been proposed as an
approach to reduce the burden of cardiovascular disease, especially in low-income and …
approach to reduce the burden of cardiovascular disease, especially in low-income and …
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from …
A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …
A polypill strategy to improve adherence: results from the FOCUS project
Background: Adherence to evidence-based cardiovascular (CV) medications after an acute
myocardial infarction (MI) is low after the first 6 months. The use of fixed-dose combinations …
myocardial infarction (MI) is low after the first 6 months. The use of fixed-dose combinations …
[HTML][HTML] Polypill for cardiovascular disease prevention in an underserved population
D Muñoz, P Uzoije, C Reynolds, R Miller… - … England Journal of …, 2019 - Mass Medical Soc
Background Persons with low socioeconomic status and nonwhite persons in the United
States have high rates of cardiovascular disease. The use of combination pills (also called …
States have high rates of cardiovascular disease. The use of combination pills (also called …
Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications
Background Older people taking multiple medications represent a large and growing
proportion of the population. Managing multiple medications can be challenging, and this is …
proportion of the population. Managing multiple medications can be challenging, and this is …
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in …
Objective To evaluate whether provision of fixed dose combination treatment improves
adherence and risk factor control compared with usual care of patients at high risk of …
adherence and risk factor control compared with usual care of patients at high risk of …
Interventions to improve adherence to lipid‐lowering medication
ML van Driel, MD Morledge, R Ulep… - Cochrane Database …, 2016 - cochranelibrary.com
Background Lipid‐lowering drugs are widely underused, despite strong evidence indicating
they improve cardiovascular end points. Poor patient adherence to a medication regimen …
they improve cardiovascular end points. Poor patient adherence to a medication regimen …